Neuropsychopharmacology
- Anti-seizure effects of WS-3, a TRPM8 agonist, on focal onset seizure mouse model via reduction of extracellular glutamate levels11 months ago
- Using causal network mapping to clarify pre-clinical brain stimulation results11 months ago
- Neurobiology of resilience to early life stress11 months ago
- The mesolimbic reward pathway is necessary for disruptions in cocaine-seeking behavior following mediated devaluation11 months ago
- Fatty acid amide hydrolase in major depressive episodes: A [11C]CURB positron emission tomography study11 months ago
- Inflammatory pain in mice induces light cycle-dependent effects on sleep architecture11 months ago
- Unraveling time-dependent genetic components underlying alcohol response11 months ago
Journal of Psychopharmacology
- Evidence-based guidelines for the interpretation of the 9-item Concise Health Risk Tracking – Self-Report (CHRT-SR9) measure of suicidal risk2 years ago
- Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment2 years ago
- Chronic Cannabis users exhibit altered oscillatory dynamics and functional connectivity serving visuospatial processing2 years ago
- A framework for assessment of adverse events occurring in psychedelic-assisted therapies2 years ago
- From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions2 years ago
- Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile “the great entactogen—empathogen debate”2 years ago
- No evidence that post-training dopamine D2 receptor agonism affects fear generalization in male rats2 years ago
European Neuropsychopharmacology
- Open science in biomedicine: Overcoming barriers in omics studies2 years ago
- Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance2 years ago
- Addressing concerns of sample overlap in meta-analysis: A response to the letter by Ben Haouala and Amamou, 20242 years ago
- Network meta-analysis (NMA) of dextromethorphan-bupropion (AXS-05) efficacy and safety in major depressive disorder2 years ago
- Points to consider when initiating clinical investigations in autistic paediatric populations–A White Paper2 years ago
- Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review2 years ago
- Methodological issues around the comorbidity of obsessive-compulsive disorder and bipolar disorder2 years ago